BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34157083)

  • 1. Influence of Klebsiella pneumoniae and quinolone treatment on prognosis in patients with pancreatic cancer.
    Weniger M; Hank T; Qadan M; Ciprani D; Michelakos T; Niess H; Heiliger C; Ilmer M; D'Haese JG; Ferrone CR; Warshaw AL; Lillemoe KD; Werner J; Liss A; Fernández-Del Castillo C
    Br J Surg; 2021 Jun; 108(6):709-716. PubMed ID: 34157083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribonucleotide reductase M2 does not predict survival in patients with resectable pancreatic adenocarcinoma.
    Xie H; Lin J; Thomas DG; Jiang W; Liu X
    Int J Clin Exp Pathol; 2012; 5(4):347-55. PubMed ID: 22670179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patients.
    Mohindroo C; Hasanov M; Rogers JE; Dong W; Prakash LR; Baydogan S; Mizrahi JD; Overman MJ; Varadhachary GR; Wolff RA; Javle MM; Fogelman DR; Lotze MT; Kim MP; Katz MHG; Pant S; Tzeng CD; McAllister F
    Cancer Med; 2021 Aug; 10(15):5041-5050. PubMed ID: 34250759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The determination of gyrA and parC mutations and the prevalence of plasmid-mediated quinolone resistance genes in carbapenem resistant Klebsiella pneumonia ST11 and ST76 strains isolated from patients in Heilongjiang Province, China.
    Zeng L; Zhang J; Li C; Fu Y; Zhao Y; Wang Y; Zhao J; Guo Y; Zhang X
    Infect Genet Evol; 2020 Aug; 82():104319. PubMed ID: 32278145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different Effects of Antibiotics on
    Chen J; Xiang Q; Wu JY; Huang XB; Wang C; Wei DQ; Lv Y
    Microb Drug Resist; 2022 Jun; 28(6):660-669. PubMed ID: 35639423
    [No Abstract]   [Full Text] [Related]  

  • 6. Survival Outcomes Associated With Clinical and Pathological Response Following Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Chemotherapy in Resected Pancreatic Cancer.
    Macedo FI; Ryon E; Maithel SK; Lee RM; Kooby DA; Fields RC; Hawkins WG; Williams G; Maduekwe U; Kim HJ; Ahmad SA; Patel SH; Abbott DE; Schwartz P; Weber SM; Scoggins CR; Martin RCG; Dudeja V; Franceschi D; Livingstone AS; Merchant NB
    Ann Surg; 2019 Sep; 270(3):400-413. PubMed ID: 31283563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unresectable pancreatic ductal adenocarcinoma: Role of CT quantitative imaging biomarkers for predicting outcomes of patients treated with chemotherapy.
    Cheng SH; Cheng YJ; Jin ZY; Xue HD
    Eur J Radiol; 2019 Apr; 113():188-197. PubMed ID: 30927946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Aspects of the antimicrobial resistence profile in infections with Escherichia coli and Klebsiella pneumoniae in diabetic patients].
    Petrovici CG; Dorobăţ C; Matei M; Teodor A; Luca V; Miftode E
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):769-75. PubMed ID: 22046785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraoperative Radiation Therapy (IORT) for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (BR/LA PDAC) in the Era of Modern Neoadjuvant Treatment: Short-Term and Long-Term Outcomes.
    Harrison JM; Wo JY; Ferrone CR; Horick NK; Keane FK; Qadan M; Lillemoe KD; Hong TS; Clark JW; Blaszkowsky LS; Allen JN; Castillo CF
    Ann Surg Oncol; 2020 May; 27(5):1400-1406. PubMed ID: 31758284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial.
    Sinn M; Bahra M; Liersch T; Gellert K; Messmann H; Bechstein W; Waldschmidt D; Jacobasch L; Wilhelm M; Rau BM; Grützmann R; Weinmann A; Maschmeyer G; Pelzer U; Stieler JM; Striefler JK; Ghadimi M; Bischoff S; Dörken B; Oettle H; Riess H
    J Clin Oncol; 2017 Oct; 35(29):3330-3337. PubMed ID: 28817370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diversified Effects of Bile Contamination, Postoperative Infections, and Antimicrobial Resistance Level on the Oncologic Prognosis After Pancreatoduodenectomy for Ductal Adenocarcinoma.
    Gianotti L; Honselmann KC; Angrisani M; Gavazzi F; Keck T; Wellner U; Bolm L; Petruch N; Capretti G; Nappo G; Bernasconi DP; Sandini M; Zerbi A
    Anticancer Res; 2022 May; 42(5):2743-2752. PubMed ID: 35489735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gentamicin therapy for sepsis due to carbapenem-resistant and colistin-resistant Klebsiella pneumoniae.
    Gonzalez-Padilla M; Torre-Cisneros J; Rivera-Espinar F; Pontes-Moreno A; López-Cerero L; Pascual A; Natera C; Rodríguez M; Salcedo I; Rodríguez-López F; Rivero A; Rodríguez-Baño J
    J Antimicrob Chemother; 2015 Mar; 70(3):905-13. PubMed ID: 25344809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of intraoperative peritoneal washing cytology for patients with potentially resectable pancreatic ductal adenocarcinoma.
    Hoshimoto S; Hishinuma S; Shirakawa H; Tomikawa M; Ozawa I; Hoshi N; Hoshi S; Hirabayashi K; Ogata Y
    Pancreatology; 2017; 17(1):109-114. PubMed ID: 27840175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional pancreatoduodenectomy versus standard pancreatoduodenectomy with portal vein resection for pancreatic ductal adenocarcinoma with portal vein invasion.
    Oba A; Ito H; Ono Y; Sato T; Mise Y; Inoue Y; Takahashi Y; Saiura A
    BJS Open; 2020 Jun; 4(3):438-448. PubMed ID: 32191395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes after extended pancreatectomy in patients with borderline resectable and locally advanced pancreatic cancer.
    Hartwig W; Gluth A; Hinz U; Koliogiannis D; Strobel O; Hackert T; Werner J; Büchler MW
    Br J Surg; 2016 Nov; 103(12):1683-1694. PubMed ID: 27686238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe Jaundice Increases Early Severe Morbidity and Decreases Long-Term Survival after Pancreaticoduodenectomy for Pancreatic Adenocarcinoma.
    Sauvanet A; Boher JM; Paye F; Bachellier P; Sa Cuhna A; Le Treut YP; Adham M; Mabrut JY; Chiche L; Delpero JR;
    J Am Coll Surg; 2015 Aug; 221(2):380-9. PubMed ID: 26206638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.
    Riediger H; Keck T; Wellner U; zur Hausen A; Adam U; Hopt UT; Makowiec F
    J Gastrointest Surg; 2009 Jul; 13(7):1337-44. PubMed ID: 19418101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of multidrug-resistant Klebsiella pneumoniae isolates.
    Hou XH; Song XY; Ma XB; Zhang SY; Zhang JQ
    Braz J Microbiol; 2015; 46(3):759-68. PubMed ID: 26413058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors and adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma.
    You DD; Lee HG; Heo JS; Choi SH; Choi DW
    J Gastrointest Surg; 2009 Sep; 13(9):1699-706. PubMed ID: 19582512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.
    Falcone M; Russo A; Iacovelli A; Restuccia G; Ceccarelli G; Giordano A; Farcomeni A; Morelli A; Venditti M
    Clin Microbiol Infect; 2016 May; 22(5):444-50. PubMed ID: 26850826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.